Skip to main navigation Skip to search Skip to main content

Antibiotic prescribing guideline recommendations in COVID-19: a systematic survey

  • Bradley J. Langford
  • , Valerie Leung
  • , Jennifer Lo
  • , Elie A. Akl
  • , Robby Nieuwlaat
  • , Tamara Lotfi
  • , Kevin A. Brown
  • , Nick Daneman
  • , Kevin L. Schwartz
  • , Holger J. Schünemann

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background: COVID-19 and antimicrobial resistance (AMR) are two intersecting public health crises. Antimicrobial overuse in patients with COVID-19 threatens to worsen AMR. Guidelines are fundamental in encouraging antimicrobial stewardship. We sought to assess the quality of antibiotic prescribing guidelines and recommendations in the context of COVID-19, and whether they incorporate principles of antimicrobial stewardship. Methods: We performed a systematic survey which included a search using the concepts “antibiotic/antimicrobial” up to November 15, 2022 of the eCOVID-19 living map of recommendations (RecMap) which aggregates guidelines across a range of international sources and all languages. Guidelines providing explicit recommendations regarding antibacterial use in COVID-19 were eligible for inclusion. Guideline and recommendation quality were assessed using the AGREE II and AGREE-REX instruments, respectively. We extracted guideline characteristics including panel representation and the presence or absence of explicit statements related to antimicrobial stewardship (i.e., judicious antibiotic use, antimicrobial resistance or adverse effects as a consequence of antibiotic use). We used logistic regression to evaluate the relationship between guideline characteristics including quality and incorporation of antimicrobial stewardship principles. Protocol registration (OSF): https://osf.io/4pgtc. Findings: Twenty-eight guidelines with 63 antibiotic prescribing recommendations were included. Recommendations focused on antibiotic initiation (n = 52, 83%) and less commonly antibiotic selection (n = 13, 21%), and duration of therapy (n = 15, 24%). Guideline and recommendation quality varied widely. Twenty (71%) guidelines incorporated at least one concept relating to antimicrobial stewardship. Including infectious diseases expertise on the guideline panel (OR 9.44, 97.5% CI: 1.09–81.59) and AGREE-REX score (OR 3.26, 97.5% CI: 1.14–9.31 per 10% increase in overall score) were associated with a higher odds of guidelines addressing antimicrobial stewardship. Interpretation: There is an opportunity to improve antibiotic prescribing guidelines in terms of both quality and incorporation of antimicrobial stewardship principles. These findings can help guideline developers better address antibiotic stewardship in future recommendations beyond COVID-19. Funding: This project was funded by Michael G. DeGroote Cochrane Canada and McMaster GRADE centres.

Original languageEnglish
Article number102257
JournaleClinicalMedicine
Volume65
DOIs
StatePublished - Nov 2023

Keywords

  • Antibiotic prescribing
  • Antimicrobial resistance
  • Antimicrobial stewardship
  • COVID-19
  • Practice guidelines

Fingerprint

Dive into the research topics of 'Antibiotic prescribing guideline recommendations in COVID-19: a systematic survey'. Together they form a unique fingerprint.

Cite this